High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma

British Journal of Haematology

Volumn 131, Issue 5, 2005, Pages 596-608

  Rust, Renata ^a   Visser, Lydia ^a   Van Der Leij, Judith ^a   Harms, Geert ^a   Blokzijl, Tjasso ^a   Deloulme, Jean C ^b   Van Der Vlies, Pieter ^a   Kamps, Willem ^a   Kok, Klaas ^a   Lim, Megan ^c   Poppema, Sibrand ^a   Van Den Berg, Anke ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b CEA GRENOBLE   (France)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

1q12 21 amplicon; ALCL; CALM2; S100A10; S100A11

Indexed keywords

CALCIUM BINDING PROTEIN; CLATHRIN ASSEMBLY PROTEIN; DNA; MESSENGER RNA; PROTEIN S 100; CALM2 PROTEIN, HUMAN; CALMODULIN; GALECTIN 1; LAPTM5 PROTEIN, HUMAN; LIPOCORTIN 2; MEMBRANE PROTEIN; S100 CALCIUM BINDING PROTEIN A10; S100A11 PROTEIN, HUMAN;

AMPLICON; ARTICLE; CARCINOGENESIS; CELL LINE; COMPARATIVE STUDY; DOWN REGULATION; GENE AMPLIFICATION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; CALCIUM SIGNALING; CD4+ T LYMPHOCYTE; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HISTIOCYTIC LYMPHOMA; METABOLISM; METHODOLOGY; TUMOR CELL LINE;

ANNEXIN A2; CALCIUM SIGNALING; CALMODULIN; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; DOWN-REGULATION; GALECTIN 1; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE-CELL; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 PROTEINS;

EID: 33644809471     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05816.x     Document Type: Article

References (50)

1. Adra C.N. Zhu S. Ko J.L. Guillemot J.C. Cuervo A.M. Kobayashi H. Horiuchi T. Lelias J.M. Rowley J.D. Lim B. ( 1996) LAPTM5: a novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Genomics, 35, 328 337.
2. Bashir M.S. Jones D.B. Wright D.H. ( 1992) Alpha-1 anti-trypsin and CD30 expression occur in parallel in activated T cells. Clinical and Experimental Immunology, 88, 543 547.
3. Bhattacharya S. Bunick C.G. Chazin W.J. ( 2004) Target selectivity in EF-hand calcium binding proteins. Biochimica et Biophysica ACTA, 1742, 69 79.
4. Brem R. Oraszlan-Szovik K. Foser S. Bohrmann B. Certa U. ( 2003) Inhibition of proliferation by 1-8U in interferon-alpha-responsive and non-responsive cell lines. Cellular and Molecular Life Science, 60, 1235 1248.
5. Carbone A. Gloghini A. De Re V. Tamaro P. Boiocchi M. Volpe R. ( 1990) Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens. Cancer, 66, 2547 2556.
6. Choi K.S. Ghuman J. Kassam G. Kang H.M. Fitzpatrick S.L. Waisman D.M. ( 1998) Annexin II tetramer inhibits plasmin-dependent fibrinolysis. Biochemistry, 37, 648 655.
7. Cross S.S. Hamdy F.C. Deloulme J.C. Rehman I. ( 2005) Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology, 46, 256 269.
8. Deloulme J.C. Assard N. Mbele G.O. Mangin C. Kuwano R. Baudier J. ( 2000) S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivo. Journal of Biological Chemistry, 275, 35302 35310.
9. El-Rifai W. Moskaluk C.A. Abdrabbo M.K. Harper J. Yoshida C. Riggins G.J. Frierson Jr., H.F. Powell S.M. ( 2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer Research, 62, 6823 6826.
10. Feinberg A.P. ( 2004) The epigenetics of cancer etiology. Seminars in Cancer Biology, 14, 427 432.
11. Gaiser T. Thorns C. Merz H. Noack F. Feller A.C. Lange K. ( 2002) Gene profiling in anaplastic large-cell lymphoma derived cell lines with cDNA expression arrays. Journal of Hematotherapy & Stem Cell Research, 11, 423 428.
12. Gogusev J. Telvi L. Nezelof C. ( 2002) Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines. Cancer Genetics and Cytogenetics, 138, 95 101.
13. Hayami Y. Iida S. Nakazawa N. Hanamura I. Kato M. Komatsu H. Miura I. Dave B.J. Sanger W.G. Lim B. Taniwaki M. Ueda R. ( 2003) Inactivation of the E3/LAPTm5 gene by chromosomal rearrangement and DNA methylation in human multiple myeloma. Leukemia, 17, 1650 1657.
14. Heizmann C.W. Fritz G. Schafer B.W. ( 2002) S100 proteins: structure, functions and pathology. Frontiers in Bioscience, 7, 1356 1368.
15. Henriet P. Blavier L. Declerck Y.A. ( 1999) Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS, 107, 111 119.
16. Hisamatsu T. Watanabe M. Ogata H. Ezaki T. Hozawa S. Ishii H. Kanai T. Hibi T. ( 1999) Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis. Cancer Research, 59, 5927 5931.
17. Huo X. Zhang J. ( 2005) Important roles of reversible acetylation in the function of hematopoietic transcription factors. Journal of Cellular and Molecular Medicine, 9, 103 112.
18. Jacobs E. Bulpitt P.C. Coutts I.G. Robertson J.F. ( 2000) New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor status. Anticancer Drugs, 11, 63 68.
19. Jones S.E. Jomary C. ( 2002) Clusterin. International Journal of Biochemistry and Cell Biology, 34, 427 431.
20. Juco J. Holden J.T. Mann K.P. Kelley L.G. Li S. ( 2003) Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. American Journal of Clinical Pathology, 119, 205 212.
21. Kok K. Dijkhuizen T. Swart Y.E. Zorgdrager H. van der Vlies P. Fehrmann R. te Meerman G.J. Gerssen-Schoorl K.B.J. van Essen T. Sikkema-Raddatz B. Buys C.H.C.M. ( 2005) Application of comprehensive subtelomere array in clinical diagnosis of mental retardation. European Journal of Medical Genetics, 48, 250 262.
22. Kruger A. Fata J.E. Khokha R. ( 1997) Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice. Blood, 90, 1993 2000.
23. van der Leij J. van den Berg A. Albrecht E.W. Blokzijl T. Roozendaal R. Gouw A.S. de Jong K.P. Stegeman C.A. van Goor H. Chang N.S. Poppema S. ( 2003) High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells. Transplantation, 75, 2076 2082.
24. Lund A.H. van Lohuizen M. ( 2004) Epigenetics and cancer. Genes and Development, 18, 2315 2335.
25. Mao X. Orchard G. Lillington D.M. Russell-Jones R. Young B.D. Whittaker S. ( 2003) Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma. Genes, Chromosomes and Cancer, 37, 176 185.
26. Marenholz I. Heizmann C.W. Fritz G. ( 2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochemical and Biophysical Research Communications, 322, 1111 1122.
27. Mori N. Yatabe Y. Oka K. Yokose T. Ishido T. Kikuchi M. Asai J. ( 1994) Primary gastric Ki-1 positive anaplastic large cell lymphoma: a report of two cases. Pathology International, 44, 164 169.
28. Nascimento A.F. Pinkus J.L. Pinkus G.S. ( 2004) Clusterin, a marker for anaplastic large cell lymphoma immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms. American Journal of Clinical Pathology, 121, 709 717.
29. O'Connor N.T. Stein H. Gatter K.C. Wainscoat J.S. Crick J. Al Saati T. Falini B. Delsol G. Mason D.Y. ( 1987) Genotypic analysis of large cell lymphomas which express the Ki-1 antigen. Histopathology, 11, 733 740.
30. Ohshima H. Kikuchi M. Masuda Y. Yoshida T. Mohtai H. Eguchi F. Kimura N. Takihara Y. ( 1990) Genotypic and immunophenotypic analysis of anaplastic large cell lymphoma (Ki-1 lymphoma). Pathology, Research and Practice, 186, 582 588.
31. Pace K.E. Hahn H.P. Pang M. Nguyen J.T. Baum L.G. ( 2000) CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. Journal of Immunology, 165, 2331 2334.
32. Pinkel D. Segraves R. Sudar D. Clark S. Poole I. Kowbel D. Collins C. Kuo W.L. Chen C. Zhai Y. Dairkee S.H. Ljung B.M. Gray J.W. Albertson D.G. ( 1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genetics, 20, 207 211.
33. Pittaluga S. Wlodarska I. Pulford K. Campo E. Morris S.W. van den Berghe H. de Wolf-Peeters C. ( 1997) The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. American Journal of Pathology, 151, 343 351.
34. Rappl G. Abken H. Muche J.M. Sterry W. Tilgen W. Andre S. Kaltner H. Ugurel S. Gabius H.J. Reinhold U. ( 2002) CD4+CD7- leukemic T cells from patients with Sezary syndrome are protected from galectin-1-triggered T cell death. Leukemia, 16, 840 845.
35. Rimokh R. Magaud J.P. Berger F. Samarut J. Coiffier B. Germain D. Mason D.Y. ( 1989) A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma). British Journal of Haematology, 71, 31 36.
36. Rust R. Harms G. Blokzijl T. Boot M. Diepstra A. Kluiver J. Visser L. Peh S.C. Lim M. Kamps W.A. Poppema S. van den Berg A. ( 2005) High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma. Journal of Clinical Pathology, 58, 520 524.
37. Sakaguchi M. Miyazaki M. Takaishi M. Sakaguchi Y. Makino E. Kataoka N. Yamada H. Namba M. Huh N.H. ( 2003) S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. Journal of Cell Biology, 163, 825 835.
38. Seimiya M. O-Wang J. Bahar R. Kawamura K. Wang Y. Saisho H. Tagawa M. ( 2003) Stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation: elevated expression in human B lymphomas. International Journal of Oncology, 22, 301 304.
39. Sherman C.G. Zielenska M. Lorenzana A.N. Pulford K.A. Mason D.Y. Hutchison R.E. Thorner P.S. ( 2001) Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation. Pediatric and Developmental Pathology, 4, 129 137.
40. Skinnider B.F. Connors J.M. Sutcliffe S.B. Gascoyne R.D. ( 1999) Anaplastic large cell lymphoma: a clinicopathologic analysis. Hematological Oncology, 17, 137 148.
41. Stein H. Mason D.Y. Gerdes J. O'Connor N. Wainscoat J. Pallesen G. Gatter K. Falini B. Delsol G. Lemke H. ( 1985) The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cell. Blood, 66, 848 858.
42. Stein H. Foss H.D. Durkop H. Marafioti T. Delsol G. Pulford K. Pileri S. Falini B. ( 2000) CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood, 96, 3681 3695.
43. Sun Z. Yang P. ( 2004) Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncology, 5, 182 190.
44. Teratani T. Watanabe T. Kuwahara F. Kumagai H. Kobayashi S. Aoki U. Ishikawa A. Arai K. Nozawa R. ( 2002) Induced transcriptional expression of calcium-binding protein S100A1 and S100A10 genes in human renal cell carcinoma. Cancer Letters, 175, 71 77.
45. Trougakos I.P. Lourda M. Agiostratidou G. Kletsas D. Gonos E.S. ( 2005) Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radical Biology and Medicine, 38, 436 449.
46. Velculescu V.E. Zhang L. Vogelstein B. Kinzler K.W. ( 1995) Serial analysis of gene expression. Science, 270, 484 487.
47. Villalva C. Trempat P. Greenland C. Thomas C. Girard J.P. Moebius F. Delsol G. Brousset P. ( 2002) Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma. British Journal of Haematology, 118, 791 798.
48. Wellmann A. Thieblemont C. Pittaluga S. Sakai A. Jaffe E.S. Siebert P. Raffled M. ( 2000) Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. Blood, 96, 398 404.
49. Zettl A. Rudiger T. Konrad M.A. Chott A. Simonitsch-Klupp I. Sonnen R. Muller-Hermelink H.K. Ott G. ( 2004) Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. American Journal of Pathology, 164, 1837 1848.
50. Zhang L. Fogg D.K. Waisman D.M. ( 2004) RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. Journal of Biological Chemistry, 279, 2053 2062.